BioLight Life Sciences Ltd (BOLT) — Cash Flow Quality Index
BioLight Life Sciences Ltd (BOLT) has a Cash Flow Quality Index of -5.40x as of June 2024. Operating cash flow of ILA-4.53 Million is below net income of ILA838.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore BOLT strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BioLight Life Sciences Ltd Cash Flow Quality Index (2018–2021)
Historical Cash Flow Quality Index for BioLight Life Sciences Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check BOLT tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for BioLight Life Sciences Ltd (2018–2021)
Year-by-year earnings quality comparison for BioLight Life Sciences Ltd. For live market cap and the full company financial profile, see market value of BioLight Life Sciences Ltd.
| Year | Quality Index | Operating CF (ILA) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -26.25x | ILA-10.03 Million | ILA382.00K | ▼ -5947.0% |
| 2018 | -0.43x | ILA-22.39 Million | ILA51.59 Million | — |